Interaction of olanzapine with fluvoxamine

Psychopharmacology

Volumn 155, Issue 2, 2001, Pages 219-220

  De Jong, J ^a   Hoogenboom, B ^a   Van Troostwijk, L D ^a   De Haan, L ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; OLANZAPINE; PAROXETINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; LETTER; MUSCLE RIGIDITY; MYDRIASIS; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME; TREMOR;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DEPRESSIVE DISORDER; DRUG INTERACTIONS; FEMALE; FLUVOXAMINE; HUMANS; PIRENZEPINE; SCHIZOPHRENIA;

EID: 0035022493     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100713     Document Type: Letter

References (12)

1. Olanzapine pharmacokinetic and pharmacodynamic profile
2. 2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone
3. Pharmacokinetics and drug interactions: Update for new antipsychotics
4. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine relation to extrapyramidal side effects
5. The use of caffeine for enzyme assays: A critical appraisal
6. 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
7. Validation of a HPLC assay for quantification of caffeine and paraxantine in human serum in the context of CYP1A2 phenotyping
8. Selective serotonin reuptake inhibitor-induced mydriasis
9. Pharmacokinetic and pharmacodynamic interactions between fluvoxamine and olanzapine
10. A self-rating to measure subjective effects of neuroleptic drugs: Relationships to objective psychopathology, quality of life, compliance and other clinical variables
11. Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients
12. Overview of the pharmacokinetics of fluvoxamine